Pädiatrie pp 1149-1156 | Cite as

Herzinsuffizienz und Hypoxämie

  • H. H. Kramer

Auszug

Definition. Eine Herzinsuffizienz liegt vor, wenn das Herz nicht in der Lage ist, ein für den metabolischen Bedarf des Organismus ausreichendes Herzminutenvolumen zu fördern.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Benitz WE, Malachowski N, Cohen RS, Stevenson DK, Ariagno RL, Sunshine P (1985) Use of sodium nitroprusside in neonates: efficacy and safety. J Pediatr 106: 102–110CrossRefPubMedGoogle Scholar
  2. Buchhorn R, Kramer HH (2005) Chronische Herzinsuffizienz im Kindesalter. In: Deutsche Gesellschaft für Pädiatrische Kardiologie (Hrsg) Leitlinien zur rationalen Diagnostik und Therapie von Erkrankungen des Herzens und des Kreislaufs bei Kindern und Jugendlichen. Steinkopff, DarmstadtGoogle Scholar
  3. Buchhorn R, Hulpke-Wette M et al. (2001) Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHFPRO-INFANT Trial. Int J Cardiol 79:176–183CrossRefGoogle Scholar
  4. Cohn JN (1993) Efficacy of vasodilators in the treatment of heart failure. JACC 22 (Suppl A): 135A–138ACrossRefPubMedGoogle Scholar
  5. Feldman AM, Bristow MR (1990) The β-adrenergic pathway in the failing human heart: Implications for inotropic therapy. Cardiology 77(Suppl 1): 1–32CrossRefPubMedGoogle Scholar
  6. Fink C, Schranz D (2005) Akute Herzinsuffizienz im Kindesalter. In: Deutsche Gesellschaft für Pädiatrische Kardiologie (Hrsg) Leitlinien zur rationalen Diagnostik und Therapie von Erkrankungen des Herzens und des Kreislaufs bei Kindern und Jugendlichen. Steinkopff, DarmstadtGoogle Scholar
  7. Fisher DG, Schwartz PH, Davis AL (1993) Pharmacokinetics of exogenous epinephrine in critically ill children. Crit Care Med 21:111–117CrossRefPubMedGoogle Scholar
  8. Garg R, Yusuf S for the Collaborative Group on the ACE Inhibitor Trials (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 273:1450–1456CrossRefPubMedGoogle Scholar
  9. Habib DM, Padbury JF, Anas NG, Perkin RM, Minegar C (1992) Dobutamine pharmacokinetics and pharmacodynamics in pediatricc intensive care patients. Crit Care Med 20:601–608CrossRefPubMedGoogle Scholar
  10. Hoffman TM, Wernovsky G, Atz AM et al. (2003) Efficacy and safety of milrinone in preventing low cardiac outpunt in infants and children after corrective surgery for congenital heart disease. Circulation 107: 996–1002CrossRefPubMedGoogle Scholar
  11. Hsu DT, Quaegebeur JM, Michler RE et al. (1995) Heart transplantation in children with congenital heart disease. JACC26/3: 743–749CrossRefGoogle Scholar
  12. Hunt SA, Abraham WT, Chin MH et al. (2005) ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult. A Report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 112(12): 1825–1852CrossRefGoogle Scholar
  13. Kelly RA, Smith TW (1993) Digoxin in heart failure: Implications of recent trials. JACC (Suppl A): 107A–112AGoogle Scholar
  14. Koren G (1985) Interaction between digoxin and commonly coadministered drugs in children. Pediatrics 75:1032–1037PubMedGoogle Scholar
  15. Kramer HH (2003) Herzinsuffizienz. In: Reinhardt D (Hrsg) Therapie der Krankheiten des Kindesalters, 7. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 822–836Google Scholar
  16. Packer M (1992) Pathophysiology of chronic heart failure. Treatment of chronic heart failure. Lancet 340: 88–95CrossRefPubMedGoogle Scholar
  17. Reid JL, MacFadyen RJ, Squire IB, Lees KR (1993) Angiotensin-converting enzyme inhibitors in heart failure: blood pressure changes after the first dose. Am Heart J 126: 794–797CrossRefPubMedGoogle Scholar
  18. Schranz D, Bauer J, Wiemann J et al. (1994) Behandlung des akuten Lowcardiac-output-Syndroms nach Operationen angeborener Herzfehler: Stellenwert von Enoximon. Z Kardiol 83(Suppl 2): 83–89PubMedGoogle Scholar
  19. Witte MK, Stork JE, Blumer JL (1986) Diuretic therapeutics in the pediatric patient. Am J Cardiol 57: 44A–53ACrossRefPubMedGoogle Scholar

Literatur

  1. Beekman RH, Tuuri DT (1985) Acute hemodynamic effects of increasing hemoglobin concentration in children with a right to left ventricular shunt and relative anemia. J Am Coll Cardiol 15: 357–362CrossRefGoogle Scholar
  2. Nadas AS (1992) Hypoxemia. In: Fyler DC (ed) Nadas’ pediatric cardiology. Hanley & Belfus, Philadelphia, pp 73–76Google Scholar
  3. Paridon SM (1990) Consequences of chronic hypoxemia and pulmonary vascular resistance. In: A Garson, JT Bricker, McNamara DG (eds) The science and practice of peditatric cardiology. Lea & Febiger, Philadelphia London, pp 1996–2006Google Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2007

Authors and Affiliations

  • H. H. Kramer
    • 1
  1. 1.Univ.-KinderklinikKielGermany

Personalised recommendations